Bharya 3 mg - 0.02 mg tabl.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Drospirenone 3 mg (light yellow tablet); Ethinylestradiol 0,02 mg (light yellow tablet); Placebo (green tablet)
Available from:
Viatris GX BV-SRL
ATC code:
G03AA12
INN (International Name):
Drospirenone; Ethinylestradiol; Placebo
Dosage:
3 mg - 0,02 mg
Pharmaceutical form:
Tablet
Composition:
Drospirenone 3 mg; Ethinylestradiol 0.02 mg; Placebo
Administration route:
Oral use
Therapeutic area:
Drospirenone and Ethinylestradiol
Product summary:
CTI code: 475724-01 - Pack size: 24 + 4 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475724-02 - Pack size: 84 (3 x 24 + 3 x 4) - Commercialisation status: NO - Delivery mode: Medical prescription
Authorization status:
Commercialised: No
Authorization date:
2015-07-15
